James George Chopas - 18 Jun 2025 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
VP/Chief Accounting Officer
Signature
/s/ David Watson, attorney-in-fact for James Chopas
Issuer symbol
APLS
Transactions as of
18 Jun 2025
Net transactions value
$0
Form type
4
Filing time
20 Jun 2025, 16:09:25 UTC
Previous filing
11 Jun 2025
Next filing
03 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Chopas James George VP/Chief Accounting Officer C/O APELLIS PHARMACEUTICALS, INC., 100 FIFTH AVENUE, 3RD FLOOR, WALTHAM /s/ David Watson, attorney-in-fact for James Chopas 20 Jun 2025 0001836430

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Award $0 +6,250 +13% $0.000000 54,205 18 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This restricted stock unit was granted on June 18, 2025. The restricted stock unit will vest over a two-year period. Specifically, 50% of the restricted unit will vest on each of the one-year and two-year anniversaries of the grant date, contingent upon continued service.